Having a good communication is a key role for animal health companies
On Thursday 25th, the annual conference of the Vet+I Foundation, the benchmark technology platform in animal health, an initiative that brings together all private companies and institutions in the animal health sector to work on projects for the development of emerging technologies, was held in Madrid. Numerous company executives and personalities from the sector were invited, including our General Manager César Carnicer and Luisa De Arriba, our Director of Biological R&D and regulatory.
One of the themes of the day’s presentations was communication. Communication is key because of its immediacy, which feeds the conversations of our followers and customers on the web and social networks. Digital channels are now essential and inescapable. It’s where the company’s first contacts with its prospects and customers take place, where they form their own opinion about us, whether they adhere to our values, our messages and our products or reject them. Just as we need to take care of our face-to-face verbal messages and ensure their integrity and scientific validity, we need to “communicate well” in any channel. As César Carnicer commented, “communication is the new sales force of the digital age”. Communicating well also means sharing information in a way that is transparent and understandable to the entire society, to whom we must explain disease transmission and the OneHealth concept, as well as the crucial role of veterinarians in it.
Communicating well is an essential ingredient in building trust and engagement with society and avoiding mistakes that can ruin the reputation not only of a company, but of an entire sector.
The situation with Covid and radical anti-vaccination biases in general have shown that communicating science is a delicate exercise that requires adequate knowledge and resources to avoid spreading dubious information that has not been objectively and scientifically validated. Communicating well requires that all actors in the sector have “collaborative intelligence”. Collaborative intelligence, a term coined by William Isaacs in 1999, is the ability to work together to make the best decisions. This is what the participants invited by the Vet+I Foundation intend to do.
For Syva, one of the important messages to take away from this Vet+I conference is that, if we want to achieve our mission to deliver meaningful solutions for animal health, our communication must also be meaningful to society and be delivered through channels that are meaningful to today’s customers. And that is why we have to show our collaborative intelligence.
To know more about the Vet+I conference we invite you to read this article* from Diaro Veterinario. https://www.diarioveterinario.com/t/3319624/gran-respaldo-sector-xii-conferencia-fundacion-vet-i
* This article is in Spanish, but if you allow the artificial intelligence of your browser to translate this page, anything is possible.
Photo source: #Diario Veterinario
You may also be interested in
![](https://syva.es/wp-content/uploads/2025/01/Vacas-en-granjas-Paises-Bajos-copyrights-Syva-2024-823x462.png)
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
![](https://syva.es/wp-content/uploads/2025/01/Intro-del-video-explicativo-2-823x462.png)
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
![](https://syva.es/wp-content/uploads/2025/01/Syvazul-BTV3-Opinion-Positiva-CVMP-EMA--823x462.png)
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.